Invention Grant
- Patent Title: Composition and methods for the treatment of myopia
-
Application No.: US17706225Application Date: 2022-03-28
-
Publication No.: US12102628B2Publication Date: 2024-10-01
- Inventor: Hui Ouyang , Yong Qiu
- Applicant: Seinda Pharmaceutical Guangzhou Corporation
- Applicant Address: CN Guangdong
- Assignee: Seinda Pharmaceutical Guangzhou Corporation
- Current Assignee: Seinda Pharmaceutical Guangzhou Corporation
- Current Assignee Address: CN Guangdong
- Agency: Fish & Richardson P.C.
- Main IPC: A61P27/02
- IPC: A61P27/02 ; A61K9/00 ; A61K31/06 ; A61K31/216 ; A61K31/222 ; A61K31/24 ; A61K31/4168 ; A61K31/417 ; A61K31/439 ; A61K31/4406 ; A61K31/46 ; A61K31/498 ; A61K31/551 ; A61K31/5513 ; A61P27/10 ; C07C217/20 ; C07C219/10 ; C07D213/04 ; C07D235/02 ; C07D403/04 ; C07D403/12 ; C07D471/08 ; C07D487/04 ; C07D491/18
Abstract:
Compositions and methods useful in slowing, inhibiting, or regressing the progression of myopia, while minimizing pupil dilation and light sensitivity are provided herein. Provided compositions can include a muscarinic receptor antagonist and a miotic agent.
Public/Granted literature
- US20230062844A1 COMPOSITION AND METHODS FOR THE TREATMENT OF MYOPIA Public/Granted day:2023-03-02
Information query
